The results showed that while liraglutide was more effective at supporting weight loss, you were also more likely to discontinue the medication due to the severity of the side effects and adverse events
The article says baseline metabolic markers should be confirmed with the healthcare provider, naming fasting glucose, HbA1c, a lipid profile and kidney function
"The future will be more choices, and that's a great thing," Ricks said
It doesnt replace medical advice
Weekly subcutaneous VK2735, a GIP/GLP-1 receptor dual agonist, for weight management: Phase 2, randomized, 13-week VENTURE study
The goal is letting your body adjust to the medication, minimizing gastrointestinal side effects , and establishing tolerance